Sign In
Buy HALO
$69.82
+3.54 (+5.34%)
At Close: Jun 03, 2026
Halozyme Therapeutics: Chugging Along
06:46pm, Monday, 09'th Jan 2023
The stock of Halozyme Therapeutics, Inc. has moved up nicely in recent months, buoyed by solid third quarter results and positive commentary from the analyst firm community. However, Halozyme stock is
Halozyme to Present at the 41st Annual J.P. Morgan Healthcare Conference
08:30am, Tuesday, 03'rd Jan 2023
SAN DIEGO , Jan. 3, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will present at the 41st
3 Stocks to Keep an Eye on for Earnings Growth in 2023
08:16am, Wednesday, 28'th Dec 2022
As 2023 approaches, its prudent to have a look at stocks like Halozyme Therapeutics (HALO), Arista Networks (ANET) & Citizens Financial Group (CFG) for solid earnings growth.
Halozyme Therapeutics (HALO) Up 16.2% Since Last Earnings Report: Can It Continue?
12:48pm, Thursday, 08'th Dec 2022
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock?
Halozyme (HALO) Stock Rises 35% in the Year so Far: Here's Why
01:33pm, Friday, 25'th Nov 2022
Halozyme (HALO) is gaining on its proprietary drug delivery technology, ENHANZE. It expects strong revenues on the back of robust demand for its new partnered drugs.
GILD vs. HALO: Which Stock Is the Better Value Option?
12:48pm, Tuesday, 22'nd Nov 2022
GILD vs. HALO: Which Stock Is the Better Value Option?
HALO Stock: Halozyme Gets Under Your Skin To Deliver Blockbuster Drugs And Booming Growth
12:09pm, Tuesday, 15'th Nov 2022
Halozyme's under-the-skin technology helps deliver some of the biggest moneymaking injections, fueling booming growth and prospects for much more. HALO stock is surging.
Pro: ‘S&P 500 in a recession is fairly valued at 2,800 to 3,200'
12:49pm, Friday, 11'th Nov 2022
S&P 500 is breathing a much-awaited sigh of relief after the monthly inflation data came in better than expected (read more). But there's hardly a reason to believe that it's not just another one of t
Halozyme's (HALO) Q3 Earnings and Revenues Surpass Estimates
12:02pm, Wednesday, 09'th Nov 2022
Halozyme's (HALO) earnings and revenues beat estimates for the third quarter of 2022.
Halozyme Therapeutics, Inc. (HALO) Q3 2022 Earnings Call Transcript
07:00pm, Tuesday, 08'th Nov 2022
Halozyme Therapeutics, Inc. (NASDAQ:HALO ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Tram Bui - Vice President, Investor Relations & Corporate Communication Hel
Halozyme Therapeutics (HALO) Surpasses Q3 Earnings and Revenue Estimates
06:48pm, Tuesday, 08'th Nov 2022
Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 42.31% and 11.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the sto
Should You Buy Halozyme Therapeutics (HALO) Ahead of Earnings?
12:51pm, Monday, 07'th Nov 2022
Halozyme Therapeutics (HALO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Halozyme Looks Good For Their Excellent Royalty Revenue Stream
08:00am, Monday, 24'th Oct 2022
Halozyme made a smooth transition from a failed R&D company to a successful royalty company. Their Antares acquisition is a bid to delay ENHANZE IP expiry, although the autoinjector platform is no rea
Halozyme Therapeutics: A Pharma Mutual Fund In A Single Company
05:45am, Monday, 24'th Oct 2022
The new Halozyme is well-fixed to grow revenues from multiple sources over the balance of this decade and beyond. Halozyme's effective execution of its business model substantially reduces its risk pr
Halozyme Therapeutics (HALO) Down 10.6% Since Last Earnings Report: Can It Rebound?
12:47pm, Thursday, 08'th Sep 2022
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock?
